WIDE-RANGE FOR OPTIMAL CONCENTRATION OF FOLINIC ACID IN FLUOROURACIL MODULATION - EXPERIMENTAL-DATA ON HUMAN TUMOR-CELL LINES

The clinical use of the fluorouracil (FU)-folinic acid (FA) combinatio n is hampered by the still open choice of the optimal schedule, with m arked controversy as concerns the optimal FA dose. This in vitro study on FU-FA combinations in 17 human cancer cell lines, representative o f tumour types responding to FU-FA treatment, reassesses the notion of the optimal FA concentration. Cells were exposed for 5 days to variou s FU-FA concentrations (0.07-77 mu M, 14 concentrations, for FU; and 0 .0025-100 mu M for FA). The growth inhibition was assessed by the MTT test. The investigated cell lines exhibited FU IC50 ranging from 0.4 t o 38.9 mu M (median 3.7 mu M). In six out of 17 cell lines investigate d, the addition of FA did not result in a substantial enhancement of F U cytotoxicity (group 1). For the remaining 11 cell lines responding t o FA supplementation (group 2), the maximal enhancement factor ranged from 3 to 8, meaning that in the presence of optimal FA concentration, the efficient FU concentration (IC50) was reduced by between 3 and 8 as compared to the efficient FU concentration without FA supplementati on. For cell lines responding to FA supplementation, the optimal FA co ncentrations ranged from 10(-7) to 4 x 10(-4) M (4000-fold range) with a median value at 9.6 x 10(-7) M. Distribution of cell doubling time was not significantly different between group 1 and group 2. In contra st, the FU IC50 were significantly different (P = 0.02) between group 1 (median 7.4 mu M) and group 2 (median 2.2 mu M), thus indicating tha t cell lines with the greatest FU cytotoxicity enhancement by FA were those intrinsically sensitive to FU and vice versa.